Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 1
2021 12
2022 10
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer.
Moutafi MK, Molero M, Martinez Morilla S, Baena J, Vathiotis IA, Gavrielatou N, Castro-Labrador L, de Garibay GR, Adradas V, Orive D, Valencia K, Calvo A, Montuenga LM, Ponce Aix S, Schalper KA, Herbst RS, Paz-Ares L, Rimm DL, Zugazagoitia J. Moutafi MK, et al. Among authors: vathiotis ia. J Immunother Cancer. 2022 Aug;10(8):e004757. doi: 10.1136/jitc-2022-004757. J Immunother Cancer. 2022. PMID: 36002182 Free PMC article.
CD24: A Novel Target for Cancer Immunotherapy.
Panagiotou E, Syrigos NK, Charpidou A, Kotteas E, Vathiotis IA. Panagiotou E, et al. Among authors: vathiotis ia. J Pers Med. 2022 Jul 28;12(8):1235. doi: 10.3390/jpm12081235. J Pers Med. 2022. PMID: 36013184 Free PMC article. Review.
Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck.
Johnson JM, Vathiotis IA, Harshyne LA, Ali A, Bar Ad V, Axelrod R, Lorber E, Curry J, Cognetti DM, Luginbuhl AJ, Tuluc M, Keith S, Mahoney MG, Argiris A. Johnson JM, et al. Among authors: vathiotis ia. J Immunother Cancer. 2023 Aug;11(8):e007141. doi: 10.1136/jitc-2023-007141. J Immunother Cancer. 2023. PMID: 37536941 Free PMC article. Clinical Trial.
Tumor Dormancy: Implications for Invasion and Metastasis.
Gomatou G, Syrigos N, Vathiotis IA, Kotteas EA. Gomatou G, et al. Among authors: vathiotis ia. Int J Mol Sci. 2021 May 4;22(9):4862. doi: 10.3390/ijms22094862. Int J Mol Sci. 2021. PMID: 34064392 Free PMC article. Review.
High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC).
Moutafi MK, Bates KM, Aung TN, Milian RG, Xirou V, Vathiotis IA, Gavrielatou N, Angelakis A, Schalper KA, Salichos L, Rimm DL. Moutafi MK, et al. Among authors: vathiotis ia. J Immunother Cancer. 2024 Jun 10;12(6):e009039. doi: 10.1136/jitc-2024-009039. J Immunother Cancer. 2024. PMID: 38857914 Free PMC article.
Takotsubo Cardiomyopathy in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Summary of Included Cases.
Trontzas IP, Vathiotis IA, Kyriakoulis KG, Sofianidi A, Spyropoulou Z, Charpidou A, Kotteas EA, Syrigos KN; ImmunoTTS Collaborative Group. Trontzas IP, et al. Among authors: vathiotis ia. Cancers (Basel). 2023 May 6;15(9):2637. doi: 10.3390/cancers15092637. Cancers (Basel). 2023. PMID: 37174104 Free PMC article. Review.
33 results